IP Verse

Blood Therapeutics competitive analysis

Loading summary...

Latest patents of Blood Therapeutics opposed by its competitors

Explore Blood Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3102208
Jul 17, 2024Crystalline Polymorphs Of The Free Base Of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde1

Latest publications and patents of Blood Therapeutics New

Explore the latest publications and patents granted to Blood Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Blood Therapeutics

EP3102208
Jul 17, 2024Crystalline Polymorphs Of The Free Base Of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)BenzaldehydePatent Maintained As Amended

Latest PTAB cases involving Blood Therapeutics

Discover the latest PTAB cases involving Blood Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Blood Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BLOOD THERAPEUTICS - 1 - -
BULLE DR19 - - -